var data={"title":"Diabetic autonomic neuropathy of the gastrointestinal tract","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Diabetic autonomic neuropathy of the gastrointestinal tract</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/contributors\" class=\"contributor contributor_credentials\">Thomas Frieling, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/contributors\" class=\"contributor contributor_credentials\">Nicholas J Talley, MD, PhD</a></dd><dd><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/contributors\" class=\"contributor contributor_credentials\">David M Nathan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/contributors\" class=\"contributor contributor_credentials\">Shilpa Grover, MD, MPH, AGAF</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;May 24, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diabetic autonomic neuropathy may involve the cardiovascular, genitourinary, and the neuroendocrine systems as well as the upper and lower gastrointestinal (GI) tract. Abnormalities of GI function in diabetics are thought to be related, at least in part, to autonomic neuropathy of the enteric nervous system. </p><p>This topic will review the GI manifestations of diabetic autonomic neuropathy. The other manifestations of diabetic autonomic neuropathy are discussed separately. (See <a href=\"topic.htm?path=diabetic-autonomic-neuropathy\" class=\"medical medical_review\">&quot;Diabetic autonomic neuropathy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most studies assessing the prevalence of gastrointestinal GI symptoms in patients with diabetes mellitus have suggested that diabetics are more likely to experience GI symptoms as compared with controls [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/1-12\" class=\"abstract_t\">1-12</a>]. Upper GI symptoms may be more common in patients with long-term type 1 diabetes mellitus [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/13\" class=\"abstract_t\">13</a>]. However, discordant data have also been reported. The difference among studies may in part be related to the inclusion of patients with varying disease severity <span class=\"nowrap\">and/or</span> glycemic control. Furthermore, studies have not consistently used validated measures of GI symptoms [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/14\" class=\"abstract_t\">14</a>]. </p><p>The true prevalence of gastroparesis in patients with diabetes is unknown, and prevalence estimates have varied widely [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/15,16\" class=\"abstract_t\">15,16</a>]. While in early studies in tertiary medical centers, up to 60 percent of patients with longstanding type 1 diabetes mellitus and GI symptoms had diabetic gastroparesis, these studies predated the use of intensive insulin treatment [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/17\" class=\"abstract_t\">17</a>]. In a population-based study, the 10-year incidence of symptomatic gastroparesis in patients with type 1 and 2 diabetes were 5 and 1 percent, respectively [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/18\" class=\"abstract_t\">18</a>].</p><p>Estimates of the prevalence of diabetic diarrhea have varied widely between 8 and 22 percent [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/8,19\" class=\"abstract_t\">8,19</a>]. It is likely, however, that the true incidence is substantially lower. In a population-based study, for example, no differences in the prevalence of diarrhea were detected among non-insulin-dependent diabetics, insulin-dependent diabetics, and healthy controls [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/12\" class=\"abstract_t\">12</a>]. In another study that included 200 diabetic patients attending an outpatient clinic, only two complained of nocturnal diarrhea, both of whom had autonomic neuropathy [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H478192920\"><span class=\"h1\">GASTROESOPHAGEAL REFLUX DISEASE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gastroesophageal reflux refers to the retrograde passage of gastric contents into the esophagus. This is a normal, physiologic process. Gastroesophageal reflux disease (GERD) is present when reflux is associated with symptoms or complications.</p><p class=\"headingAnchor\" id=\"H1620173131\"><span class=\"h2\">Pathogenesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with diabetes, GERD may be caused by autonomic neuropathy with decreased lower esophageal sphincter (LES) pressure, increased number of transient LES relaxations due to hyperglycemia, impaired clearance function of the tubular esophagus, or delayed gastric emptying [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"topic.htm?path=pathophysiology-of-reflux-esophagitis#H2\" class=\"medical medical_review\">&quot;Pathophysiology of reflux esophagitis&quot;, section on 'Gastroesophageal junction incompetence'</a>.)</p><p class=\"headingAnchor\" id=\"H3319591346\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common symptoms of GERD are heartburn (pyrosis) and regurgitation. Other extraesophageal manifestations of GERD include bronchospasm, laryngitis, and chronic cough. Dysphagia for liquids <span class=\"nowrap\">and/or</span> solids is rarely seen in diabetes mellitus, even when disturbance of esophageal peristalsis can be found in esophageal manometry. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-gastroesophageal-reflux-in-adults#H13576047\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of gastroesophageal reflux in adults&quot;, section on 'Clinical features'</a>.)</p><p class=\"headingAnchor\" id=\"H268668400\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A presumptive diagnosis of GERD can be based upon clinical symptoms alone. The role of evaluation with upper endoscopy and ambulatory pH monitoring in patients with symptoms of GERD is discussed in detail, separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-gastroesophageal-reflux-in-adults#H4136578667\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of gastroesophageal reflux in adults&quot;, section on 'Evaluation in selected patients'</a>.)</p><p class=\"headingAnchor\" id=\"H3650233949\"><span class=\"h2\">Management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The management of GERD is based on the frequency and severity of symptoms or complications. The medical and surgical management of GERD are discussed in detail, separately. (See <a href=\"topic.htm?path=medical-management-of-gastroesophageal-reflux-disease-in-adults\" class=\"medical medical_review\">&quot;Medical management of gastroesophageal reflux disease in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">GASTROPARESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gastroparesis is a syndrome of objectively delayed gastric emptying in the absence of a mechanical obstruction and cardinal symptoms of nausea, vomiting, early satiety, bloating, <span class=\"nowrap\">and/or</span> upper abdominal pain. </p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Pathogenesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diabetic gastroparesis is thought to result from impaired neural control of gastric function. Abnormal myenteric neurotransmission, impairment of the inhibitory nitric oxide-containing nerves, damage of the pacemaker interstitial cells of Cajal, and underlying smooth muscle dysfunction have been described [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/15,16\" class=\"abstract_t\">15,16</a>]. Morphologic abnormalities include inflammatory changes in some autonomic ganglia and dropout of vagal myelinated fibers [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/15\" class=\"abstract_t\">15</a>]. Various gastric myoelectric and motor abnormalities have been observed in patients with diabetic gastroparesis (<a href=\"image.htm?imageKey=GAST%2F66160\" class=\"graphic graphic_table graphicRef66160 \">table 1</a>). </p><p>However, abnormalities of gastric emptying in diabetics are not strongly correlated with either disturbed gastroduodenal motility during manometry or clinical indices of autonomic neuropathy [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/21-24\" class=\"abstract_t\">21-24</a>]. There is also poor correlation between delayed gastric emptying and symptoms in diabetes mellitus that may be due to the involvement of the afferent sensory nerve fibers by autonomic neuropathy, thereby decreasing perception of symptoms [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/25\" class=\"abstract_t\">25</a>]. (See <a href=\"topic.htm?path=pathogenesis-of-delayed-gastric-emptying\" class=\"medical medical_review\">&quot;Pathogenesis of delayed gastric emptying&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H2266644795\"><span class=\"h3\">Effect of serum glucose on gastric emptying</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is a close, bidirectional relationship between gastric emptying and postprandial glycemia [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/5,15,26-30\" class=\"abstract_t\">5,15,26-30</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acute elevation</strong> &ndash; Acute elevations in the plasma glucose concentration affect gastric sensory and motor function [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/31\" class=\"abstract_t\">31</a>]. In diabetics with autonomic neuropathy, the induction of hyperglycemia stimulates gastric electric activity (tachygastria), whereas the electric rhythm may be normal under normoglycemic conditions [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/28,29\" class=\"abstract_t\">28,29</a>]. In healthy controls and patients with type 1 diabetes, marked acute hyperglycemia relaxes the proximal stomach; suppresses the frequency, propagation, and contraction amplitude of antral pressure waves under fasting and postprandial conditions; and stimulates phasic pyloric pressure waves, all of which retard gastric emptying [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/22,26,30,32\" class=\"abstract_t\">22,26,30,32</a>]. In addition, changes in blood glucose level within the physiological postprandial range also slow gastric emptying [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/27\" class=\"abstract_t\">27</a>]. In contrast, hypoglycemia leads to accelerated gastric emptying even in patients with delayed gastric emptying [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/33\" class=\"abstract_t\">33</a>]. The effect of acute hyperglycemia on gastric emptying in patients with type 2 diabetes has not been well studied, although both the emptying of liquids and the lag phase for solids appear to be related to the blood glucose concentration [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/34\" class=\"abstract_t\">34</a>]. These findings suggest that gastrointestinal (GI) motor function is influenced by the glycemic state and varies over relatively brief intervals [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/30\" class=\"abstract_t\">30</a>]. The slowing of gastric emptying associated with elevation of the blood glucose concentration to postprandial levels is likely to constitute a physiological mechanism that regulates the release of nutrients into the small intestine. </p><p/><p class=\"bulletIndent1\">Acute hyperglycemia also affects the sensitivity of the GI tract. In the esophagus, the threshold for perception of balloon distension is reduced by acute elevations of blood glucose concentration even within the physiological range. </p><p/><p class=\"bulletIndent1\">Increased sensitivity of the proximal stomach may be responsible for postprandial dyspeptic symptoms when the stomach is distended by a meal [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/20\" class=\"abstract_t\">20</a>]. As a result, patients with type 1 diabetes mellitus may exhibit increased perception of gastric distension with exaggerated nausea, fullness, and epigastric pain for a given distending stimulus [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/15\" class=\"abstract_t\">15</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chronic hyperglycemia</strong> &ndash; The effect of chronic hyperglycemia on gastric emptying is less clear. In one study of 87 randomly selected diabetic patients, gastric emptying of a liquid meal was slower in those with blood glucose values above 270 <span class=\"nowrap\">mg/dL</span> (15 <span class=\"nowrap\">mmol/L)</span> [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/35\" class=\"abstract_t\">35</a>]. However, evidence that long-term improvement in glycemic control improves gastric emptying are lacking [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/36\" class=\"abstract_t\">36</a>].</p><p/><p class=\"headingAnchor\" id=\"H594830102\"><span class=\"h3\">Effect of gastric emptying on serum glucose</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The rate of gastric emptying has a substantial impact on carbohydrate absorption through the release of gut peptides, such as the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/37\" class=\"abstract_t\">37</a>]. In turn, higher serum glucose levels may further worsen gastroparesis. Gastroparesis can also impair absorption of oral hypoglycemic drugs [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/38\" class=\"abstract_t\">38</a>]. (See <a href=\"#H2266644795\" class=\"local\">'Effect of serum glucose on gastric emptying'</a> above.)</p><p class=\"headingAnchor\" id=\"H2075003756\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptoms of gastroparesis include nausea, vomiting, abdominal pain, early satiety, postprandial fullness, bloating, and, in severe cases, weight loss [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/37\" class=\"abstract_t\">37</a>]. (See <a href=\"topic.htm?path=gastroparesis-etiology-clinical-manifestations-and-diagnosis#H259165581\" class=\"medical medical_review\">&quot;Gastroparesis: Etiology, clinical manifestations, and diagnosis&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=overview-of-medical-care-in-adults-with-diabetes-mellitus#H2\" class=\"medical medical_review\">&quot;Overview of medical care in adults with diabetes mellitus&quot;, section on 'Diabetes-related complications'</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diabetic gastroparesis is usually suspected in patients with nausea, vomiting, abdominal pain, early satiety, postprandial fullness, bloating, or poor glycemic control despite treatment. The diagnosis is established by evidence of delayed gastric emptying on scintigraphy in the absence of an obstructing structural lesion in the stomach or small intestine by endoscopy or imaging (eg, computed tomography or magnetic resonance enterography) [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/16,22\" class=\"abstract_t\">16,22</a>]. Diagnostic evaluation in patients with suspected gastroparesis is discussed in detail, separately. (See <a href=\"topic.htm?path=gastroparesis-etiology-clinical-manifestations-and-diagnosis#H859754\" class=\"medical medical_review\">&quot;Gastroparesis: Etiology, clinical manifestations, and diagnosis&quot;, section on 'Evaluation'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diabetic gastroparesis is not progressive, and treatment is directed toward alleviating symptoms [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/39,40\" class=\"abstract_t\">39,40</a>]. Primary treatment of gastroparesis includes improved glycemic control, dietary modification, and administration of antiemetic and prokinetic agents in symptomatic patients. Incretin-based therapies such as <a href=\"topic.htm?path=pramlintide-drug-information\" class=\"drug drug_general\">pramlintide</a> and GLP-1analogues (eg, <a href=\"topic.htm?path=exenatide-drug-information\" class=\"drug drug_general\">exenatide</a>) that retard gastric emptying should be discontinued before instituting medical treatment for gastroparesis. The management of gastroparesis is discussed separately. (See <a href=\"topic.htm?path=treatment-of-gastroparesis\" class=\"medical medical_review\">&quot;Treatment of gastroparesis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">DIABETIC DIARRHEA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic diarrhea, and rarely, steatorrhea, can occur in patients with long-term diabetes [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/41\" class=\"abstract_t\">41</a>]. </p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Pathophysiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of diabetic diarrhea is unclear, but multiple underlying mechanisms may be involved (<a href=\"image.htm?imageKey=GAST%2F69533\" class=\"graphic graphic_table graphicRef69533 \">table 2</a>). </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Disordered motility</strong> &ndash; Functional impairment of the enteric nervous system (ENS) can result in disordered motility of the small bowel and the colon [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/41,42\" class=\"abstract_t\">41,42</a>]. Diabetic autonomic neuropathy may include vagal nerve dysfunction as well as sympathetic nerve damage [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/43,44\" class=\"abstract_t\">43,44</a>]. Acute changes in blood glucose concentrations can also alter gastrointestinal sensory and motor functions. The impairment in fasting and fed intestinal motor function can cause either delayed or accelerated small bowel transit [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/19\" class=\"abstract_t\">19</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Increased intestinal secretion</strong> &ndash; Autonomic neuropathy of the ENS can also directly alter mucosal water transport and ion fluxes, resulting in intestinal fluid secretion.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Small intestinal bacterial overgrowth (SIBO)</strong> &ndash; SIBO may result from abnormal small bowel motility. Diarrhea and impaired absorption of nutrients in SIBO result from either maldigestion in the intestinal lumen, or from malabsorption at the level of the intestinal microvillus membrane due to enterocyte damage. (See <a href=\"topic.htm?path=small-intestinal-bacterial-overgrowth-etiology-and-pathogenesis#H978347923\" class=\"medical medical_review\">&quot;Small intestinal bacterial overgrowth: Etiology and pathogenesis&quot;, section on 'Pathophysiology'</a> and <a href=\"topic.htm?path=small-intestinal-bacterial-overgrowth-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Fecal incontinence</strong> &ndash; Fecal incontinence can result from voluminous stools overwhelming otherwise normal continence mechanisms in older patients or underlying anorectal dysfunction [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/45\" class=\"abstract_t\">45</a>]. Anorectal manometry in patients with fecal incontinence associated with diabetes demonstrates decreased anorectal sensation during balloon distension and reduced resting anal sphincter pressures with normal squeeze pressures. (See <a href=\"topic.htm?path=fecal-incontinence-in-adults-etiology-and-evaluation#H8\" class=\"medical medical_review\">&quot;Fecal incontinence in adults: Etiology and evaluation&quot;, section on 'Etiology and pathogenesis'</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Medications</strong> &ndash; Medications (eg, <a href=\"topic.htm?path=metformin-drug-information\" class=\"drug drug_general\">metformin</a>) and artificial sweeteners (eg, <a href=\"topic.htm?path=sorbitol-drug-information\" class=\"drug drug_general\">sorbitol</a> or polyols) can cause diarrhea in patients with diabetic mellitus [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/19,46,47\" class=\"abstract_t\">19,46,47</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other</strong> &ndash; Other rare causes of diarrhea include exocrine pancreatic insufficiency and celiac sprue, the latter being more common in type 1 diabetes [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/41,48-50\" class=\"abstract_t\">41,48-50</a>]. (See <a href=\"topic.htm?path=diagnosis-of-celiac-disease-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of celiac disease in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Reduction in the endogenous bile salt pool can potentially result from impaired ileal reabsorption secondary to accelerated small bowel transit or bile acid deconjugation due to SIBO. However, the contribution of increased fecal secretions of hydroxy fatty acids and bile salts in the pathogenesis of diabetic diarrhea remains controversial [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/41\" class=\"abstract_t\">41</a>]. </p><p/><p class=\"headingAnchor\" id=\"H921993962\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with diabetic enteropathy, the diarrhea is usually watery and painless and can occur at night. Diarrhea may be associated with fecal incontinence. Bouts of diarrhea can be episodic with intermittent normal bowel habits or even alternating with periods of constipation.</p><p/><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Diagnostic evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnostic evaluation serves to exclude other etiologies of chronic diarrhea (eg, infection, microscopic colitis) and evaluate the underlying cause of diabetic diarrhea (eg, SIBO, pancreatic insufficiency, bile salt malabsorption). A combination of several factors is present in many patients (<a href=\"image.htm?imageKey=GAST%2F69533\" class=\"graphic graphic_table graphicRef69533 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/51\" class=\"abstract_t\">51</a>]. The evaluation of chronic diarrhea and fecal incontinence is discussed in detail, separately. (See <a href=\"topic.htm?path=approach-to-the-adult-with-chronic-diarrhea-in-resource-rich-settings#H14\" class=\"medical medical_review\">&quot;Approach to the adult with chronic diarrhea in resource-rich settings&quot;, section on 'Evaluation'</a> and <a href=\"topic.htm?path=fecal-incontinence-in-adults-etiology-and-evaluation#H17\" class=\"medical medical_review\">&quot;Fecal incontinence in adults: Etiology and evaluation&quot;, section on 'Evaluation'</a>.)</p><p class=\"headingAnchor\" id=\"H3510621307\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of diabetic enteropathy includes other causes of chronic watery diarrhea. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Irritable bowel syndrome (IBS)</strong> &ndash; Patients with IBS can have<strong> </strong>chronic diarrhea with loose, watery stool, but associated recurrent abdominal pain is a primary characteristic of IBS. Patients usually experience the onset of symptoms as young adults. Symptoms of IBS often correlate with episodes of psychologic stress. Diarrhea is usually characterized as frequent loose stools of small to moderate volume. Stools generally occur during waking hours, most often in the morning or after meals. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-irritable-bowel-syndrome-in-adults#H2263560866\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of irritable bowel syndrome in adults&quot;, section on 'Diagnostic criteria'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Microscopic colitis</strong> &ndash; Microscopic colitis is characterized by chronic watery (secretory) diarrhea without bleeding. On colonoscopy, patients with microscopic colitis usually have normal-appearing colonic mucosa; biopsy is necessary to establish the diagnosis of microscopic colitis. (See <a href=\"topic.htm?path=lymphocytic-and-collagenous-colitis-microscopic-colitis-clinical-manifestations-diagnosis-and-management#H15\" class=\"medical medical_review\">&quot;Lymphocytic and collagenous colitis (microscopic colitis): Clinical manifestations, diagnosis, and management&quot;, section on 'Diagnosis'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H3243056454\"><span class=\"h2\">Management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The management of patients with diabetic diarrhea begins with general measures such as hydration and correction of electrolyte and nutrient deficiency, symptomatic treatment of diarrhea, and treatment of the underlying cause. </p><p class=\"headingAnchor\" id=\"H1310985196\"><span class=\"h3\">Supportive care</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Initial management should focus on correction of water and electrolyte imbalances, glycemic control, and restoration of associated nutritional deficiencies (eg, zinc, iron, folate, vitamin A, calcium, magnesium). Intravenous hyperalimentation may be necessary in some patients because of frequent hypoglycemic episodes resulting from insulin administration to a patient with impaired enteral delivery or delayed absorption [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/41\" class=\"abstract_t\">41</a>].</p><p class=\"headingAnchor\" id=\"H3620163477\"><span class=\"h3\">Treatment of underlying cause</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Treatment should be directed at the underlying cause of diarrhea. Patients with bacterial overgrowth should be treated with antibiotics [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/51\" class=\"abstract_t\">51</a>]. Patients with concurrent celiac disease or exocrine pancreatic insufficiency should be treated with a gluten-free diet and pancreatic enzyme supplementation, respectively. (See <a href=\"topic.htm?path=management-of-celiac-disease-in-adults#H2\" class=\"medical medical_review\">&quot;Management of celiac disease in adults&quot;, section on 'Dietary counseling'</a> and <a href=\"topic.htm?path=treatment-of-chronic-pancreatitis#H21\" class=\"medical medical_review\">&quot;Treatment of chronic pancreatitis&quot;, section on 'Lipase supplementation'</a> and <a href=\"topic.htm?path=small-intestinal-bacterial-overgrowth-management\" class=\"medical medical_review\">&quot;Small intestinal bacterial overgrowth: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1352988672\"><span class=\"h3\">Symptomatic treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Antidiarrheal agents may be used to control symptoms of diarrhea by inhibiting peristalsis, prolonging transit time, and reducing fecal volume (eg, <a href=\"topic.htm?path=loperamide-drug-information\" class=\"drug drug_general\">loperamide</a> 2 to 4 mg four times daily, <a href=\"topic.htm?path=codeine-drug-information\" class=\"drug drug_general\">codeine</a> 30 mg four times daily, or diphenoxylate 5 mg four times daily) [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/41\" class=\"abstract_t\">41</a>]. </p><p>Treatment of fecal incontinence involves bulking agents and antidiarrheals to reduce stool frequency and improve stool consistency and biofeedback therapy [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/52,53\" class=\"abstract_t\">52,53</a>]. (See <a href=\"topic.htm?path=fecal-incontinence-in-adults-management\" class=\"medical medical_review\">&quot;Fecal incontinence in adults: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3709747380\"><span class=\"h3\">Other</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although other therapies have been evaluated in patients with diabetic diarrhea, there are limited data to support their use and they cannot be routinely recommended. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=clonidine-drug-information\" class=\"drug drug_general\">Clonidine</a> &ndash; Clonidine decreases intestinal transit and small intestinal secretion, but its use is limited by adverse effects (eg, orthostatic hypotension, delayed gastric emptying) [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/54,55\" class=\"abstract_t\">54,55</a>].<br/></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=octreotide-drug-information\" class=\"drug drug_general\">Octreotide</a> &ndash; Data on the use of long-acting somatostatin analogue octreotide (50 to 75 mcg subcutaneously twice daily to three times daily) in patients with diabetic diarrhea are limited to a small number of case reports [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/41,56-59\" class=\"abstract_t\">41,56-59</a>]. In addition, the use of octreotide may be complicated by recurrent episodes of hypoglycemia that may be related to reduced secretion of counter-regulatory hormones [<a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/58\" class=\"abstract_t\">58</a>]. Furthermore, octreotide may inhibit exocrine pancreatic secretion and can therefore aggravate steatorrhea. </p><p/><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon. </p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=gastroparesis-delayed-gastric-emptying-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Gastroparesis (delayed gastric emptying) (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abnormalities of gastrointestinal (GI) function in diabetics are thought to be related, at least in part, to autonomic neuropathy of the enteric nervous system. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>GI manifestations of diabetic autonomic neuropathy include gastroesophageal reflux disease (GERD), gastroparesis, and chronic diarrhea. Upper GI symptoms may be more common in patients with longstanding type 1 diabetes mellitus. Poor glycemic control may be an independent risk factor for upper GI symptoms. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>GERD may be caused by autonomic neuropathy with decreased lower esophageal sphincter (LES) pressure, increased number of transient LES relaxations due to hyperglycemia, impaired clearance function of the tubular esophagus, or delayed gastric emptying. (See <a href=\"#H478192920\" class=\"local\">'Gastroesophageal reflux disease'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The 10-year incidence of symptomatic gastroparesis in patients with type 1 and 2 diabetes are 5 and 1 percent, respectively. Symptoms of gastroparesis include nausea, vomiting, early satiety, bloating, <span class=\"nowrap\">and/or</span> upper abdominal pain. Patients with diabetic gastroparesis may also present with symptoms that are not directly related to the gastroparesis, but are due to complications of poor glycemic control. (See <a href=\"#H2075003756\" class=\"local\">'Clinical manifestations'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of diabetic gastroparesis is established by evidence of delayed gastric emptying on scintigraphy in the absence of an obstructing structural lesion in the stomach or small intestine by endoscopy or imaging (eg, computed tomography or magnetic resonance enterography). (See <a href=\"#H6\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Primary treatment of diabetic gastroparesis includes improved glycemic control, dietary modification, and administration of antiemetic and prokinetic agents in symptomatic patients. Incretin-based therapies such as <a href=\"topic.htm?path=pramlintide-drug-information\" class=\"drug drug_general\">pramlintide</a> and glucagon-like peptide-1 analogues (eg, <a href=\"topic.htm?path=exenatide-drug-information\" class=\"drug drug_general\">exenatide</a>) that delay gastric emptying should be discontinued before initiating pharmacologic therapy for gastroparesis. (See <a href=\"#H8\" class=\"local\">'Management'</a> above and <a href=\"topic.htm?path=treatment-of-gastroparesis\" class=\"medical medical_review\">&quot;Treatment of gastroparesis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diarrhea, and rarely steatorrhea, can occur in diabetics, particularly those with advanced disease. The diarrhea is watery and painless, occurs at night, and may be associated with fecal incontinence. Bouts of diarrhea can be episodic with intermittent, normal bowel habits or even alternating with periods of constipation. (See <a href=\"#H921993962\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diabetic diarrhea may be due to altered motility, increased fluid secretion, small intestinal bacterial overgrowth (SIBO), celiac disease, exocrine pancreatic insufficiency, bile salt malabsorption, medications, sorbitol-containing foods, or fecal incontinence due to anorectal dysfunction. (See <a href=\"#H11\" class=\"local\">'Pathophysiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Management of diabetic diarrhea includes general measures such as hydration and correction of electrolyte and nutrient deficiency, symptomatic treatment of diarrhea with antidiarrheals, and treatment of the underlying cause (eg, SIBO, celiac disease). (See <a href=\"#H3243056454\" class=\"local\">'Management'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/1\" class=\"nounderline abstract_t\">Sp&aring;ng&eacute;us A, El-Salhy M, Suhr O, et al. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand J Gastroenterol 1999; 34:1196.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/2\" class=\"nounderline abstract_t\">Ricci JA, Siddique R, Stewart WF, et al. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol 2000; 35:152.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/3\" class=\"nounderline abstract_t\">Ko GT, Chan WB, Chan JC, et al. Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus. Diabet Med 1999; 16:670.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/4\" class=\"nounderline abstract_t\">Locke GR 3rd. Epidemiology of gastrointestinal complications of diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7:711.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/5\" class=\"nounderline abstract_t\">Bytzer P, Talley NJ, Hammer J, et al. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 2002; 97:604.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/6\" class=\"nounderline abstract_t\">Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001; 161:1989.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/7\" class=\"nounderline abstract_t\">Lluch I, Ascaso JF, Mora F, et al. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999; 94:919.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/8\" class=\"nounderline abstract_t\">Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98:378.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/9\" class=\"nounderline abstract_t\">Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 1989; 84:868.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/10\" class=\"nounderline abstract_t\">Maser RE, Pfeifer MA, Dorman JS, et al. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990; 150:1218.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/11\" class=\"nounderline abstract_t\">Maxton DG, Whorwell PJ. Functional bowel symptoms in diabetes--the role of autonomic neuropathy. Postgrad Med J 1991; 67:991.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/12\" class=\"nounderline abstract_t\">Janatuinen E, Pikkarainen P, Laakso M, Py&ouml;r&auml;l&auml; K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol 1993; 28:427.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/13\" class=\"nounderline abstract_t\">Schvarcz E, Palm&eacute;r M, Ingberg CM, et al. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 1996; 13:478.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/14\" class=\"nounderline abstract_t\">Quan C, Talley NJ, Cross S, et al. Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther 2003; 17:1179.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/15\" class=\"nounderline abstract_t\">Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127:1592.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/16\" class=\"nounderline abstract_t\">Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127:1589.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/17\" class=\"nounderline abstract_t\">Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol 2011; 9:5.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/18\" class=\"nounderline abstract_t\">Choung RS, Locke GR 3rd, Schleck CD, et al. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol 2012; 107:82.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/19\" class=\"nounderline abstract_t\">Dandona P, Fonseca V, Mier A, Beckett AG. Diarrhea and metformin in a diabetic clinic. Diabetes Care 1983; 6:472.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/20\" class=\"nounderline abstract_t\">Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24:371.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/21\" class=\"nounderline abstract_t\">Horowitz M, Edelbroek M, Fraser R, et al. Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment. Scand J Gastroenterol 1991; 26:673.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/22\" class=\"nounderline abstract_t\">Mearin F, Malagelada JR. Gastroparesis and dyspepsia in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7:717.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/23\" class=\"nounderline abstract_t\">Buysschaert M, Moulart M, Urbain JL, et al. Impaired gastric emptying in diabetic patients with cardiac autonomic neuropathy. Diabetes Care 1987; 10:448.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/24\" class=\"nounderline abstract_t\">Wegener M, B&ouml;rsch G, Schaffstein J, et al. Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis 1990; 8:23.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/25\" class=\"nounderline abstract_t\">Rathmann W, Enck P, Frieling T, Gries FA. Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care 1991; 14:1086.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/26\" class=\"nounderline abstract_t\">Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94:739.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/27\" class=\"nounderline abstract_t\">Schvarcz E, Palm&eacute;r M, Aman J, et al. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 1997; 113:60.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/28\" class=\"nounderline abstract_t\">Jebbink HJ, Bruijs PP, Bravenboer B, et al. Gastric myoelectrical activity in patients with type I diabetes mellitus and autonomic neuropathy. Dig Dis Sci 1994; 39:2376.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/29\" class=\"nounderline abstract_t\">Jebbink RJ, Samsom M, Bruijs PP, et al. Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. Gastroenterology 1994; 107:1390.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/30\" class=\"nounderline abstract_t\">Rayner CK, Horowitz M. Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited? J Clin Invest 2006; 116:299.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/31\" class=\"nounderline abstract_t\">Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33:675.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/32\" class=\"nounderline abstract_t\">Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut 1991; 32:475.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/33\" class=\"nounderline abstract_t\">Russo A, Stevens JE, Chen R, et al. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes. J Clin Endocrinol Metab 2005; 90:4489.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/34\" class=\"nounderline abstract_t\">Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32:151.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/35\" class=\"nounderline abstract_t\">Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18:229.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/36\" class=\"nounderline abstract_t\">Chang J, Russo A, Bound M, et al. A 25-year longitudinal evaluation of gastric emptying in diabetes. Diabetes Care 2012; 35:2594.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/37\" class=\"nounderline abstract_t\">Bharucha AE, Batey-Schaefer B, Cleary PA, et al. Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus. Gastroenterology 2015; 149:330.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/38\" class=\"nounderline abstract_t\">Groop LC, Luzi L, DeFronzo RA, Melander A. Hyperglycaemia and absorption of sulphonylurea drugs. Lancet 1989; 2:129.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/39\" class=\"nounderline abstract_t\">Kong MF, Horowitz M, Jones KL, et al. Natural history of diabetic gastroparesis. Diabetes Care 1999; 22:503.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/40\" class=\"nounderline abstract_t\">Jones KL, Russo A, Berry MK, et al. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 2002; 113:449.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/41\" class=\"nounderline abstract_t\">von der Ohe MR. Diarrhoea in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7:730.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/42\" class=\"nounderline abstract_t\">He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001; 121:427.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/43\" class=\"nounderline abstract_t\">Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980; 92:301.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/44\" class=\"nounderline abstract_t\">Low PA, Walsh JC, Huang CY, McLeod JG. The sympathetic nervous system in alcoholic neuropathy. A clinical and pathological study. Brain 1975; 98:357.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/45\" class=\"nounderline abstract_t\">Wald A. Incontinence and anorectal dysfunction in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7:737.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/46\" class=\"nounderline abstract_t\">Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther 2001; 15:137.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/47\" class=\"nounderline abstract_t\">Badiga MS, Jain NK, Casanova C, Pitchumoni CS. Diarrhea in diabetics: the role of sorbitol. J Am Coll Nutr 1990; 9:578.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/48\" class=\"nounderline abstract_t\">el Newihi H, Dooley CP, Saad C, et al. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig Dis Sci 1988; 33:705.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/49\" class=\"nounderline abstract_t\">Shanahan F, McKenna R, McCarthy CF, Drury MI. Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing. Q J Med 1982; 51:329.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/50\" class=\"nounderline abstract_t\">Cudworth AG, Woodrow JC. Genetic susceptibility in diabetes mellitus: analysis of the HLA association. Br Med J 1976; 2:846.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/51\" class=\"nounderline abstract_t\">Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993; 68:691.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/52\" class=\"nounderline abstract_t\">Frieling T. [Diagnostic in anorectal disorders]. Praxis (Bern 1994) 2007; 96:243.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/53\" class=\"nounderline abstract_t\">Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med 1984; 310:1282.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/54\" class=\"nounderline abstract_t\">Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Studies of the antidiarrheal action of clonidine. Effects on motility and intestinal absorption. Gastroenterology 1985; 89:982.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/55\" class=\"nounderline abstract_t\">Fedorak RN, Field M, Chang EB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med 1985; 102:197.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/56\" class=\"nounderline abstract_t\">Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325:1461.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/57\" class=\"nounderline abstract_t\">Dudl RJ, Anderson DS, Forsythe AB, et al. Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995. Am J Med 1987; 83:584.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/58\" class=\"nounderline abstract_t\">Mourad FH, Gorard D, Thillainayagam AV, et al. Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut 1992; 33:1578.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-autonomic-neuropathy-of-the-gastrointestinal-tract/abstract/59\" class=\"nounderline abstract_t\">Walker JJ, Kaplan DS. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea. Am J Gastroenterol 1993; 88:765.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2643 Version 15.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H14\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H478192920\" id=\"outline-link-H478192920\">GASTROESOPHAGEAL REFLUX DISEASE</a><ul><li><a href=\"#H1620173131\" id=\"outline-link-H1620173131\">Pathogenesis</a></li><li><a href=\"#H3319591346\" id=\"outline-link-H3319591346\">Clinical manifestations</a></li><li><a href=\"#H268668400\" id=\"outline-link-H268668400\">Diagnosis</a></li><li><a href=\"#H3650233949\" id=\"outline-link-H3650233949\">Management</a></li></ul></li><li><a href=\"#H4\" id=\"outline-link-H4\">GASTROPARESIS</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Pathogenesis</a><ul><li><a href=\"#H2266644795\" id=\"outline-link-H2266644795\">- Effect of serum glucose on gastric emptying</a></li><li><a href=\"#H594830102\" id=\"outline-link-H594830102\">- Effect of gastric emptying on serum glucose</a></li></ul></li><li><a href=\"#H2075003756\" id=\"outline-link-H2075003756\">Clinical manifestations</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Diagnosis</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Management</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">DIABETIC DIARRHEA</a><ul><li><a href=\"#H11\" id=\"outline-link-H11\">Pathophysiology</a></li><li><a href=\"#H921993962\" id=\"outline-link-H921993962\">Clinical manifestations</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Diagnostic evaluation</a></li><li><a href=\"#H3510621307\" id=\"outline-link-H3510621307\">Differential diagnosis</a></li><li><a href=\"#H3243056454\" id=\"outline-link-H3243056454\">Management</a><ul><li><a href=\"#H1310985196\" id=\"outline-link-H1310985196\">- Supportive care</a></li><li><a href=\"#H3620163477\" id=\"outline-link-H3620163477\">- Treatment of underlying cause</a></li><li><a href=\"#H1352988672\" id=\"outline-link-H1352988672\">- Symptomatic treatment</a></li><li><a href=\"#H3709747380\" id=\"outline-link-H3709747380\">- Other</a></li></ul></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H16307554\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/2643|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/66160\" class=\"graphic graphic_table\">- Delayed gastric emptying in DM</a></li><li><a href=\"image.htm?imageKey=GAST/69533\" class=\"graphic graphic_table\">- Mechanisms of diabetic diarrhea</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-chronic-diarrhea-in-resource-rich-settings\" class=\"medical medical_review\">Approach to the adult with chronic diarrhea in resource-rich settings</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-gastroesophageal-reflux-in-adults\" class=\"medical medical_review\">Clinical manifestations and diagnosis of gastroesophageal reflux in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-irritable-bowel-syndrome-in-adults\" class=\"medical medical_review\">Clinical manifestations and diagnosis of irritable bowel syndrome in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diabetic-autonomic-neuropathy\" class=\"medical medical_review\">Diabetic autonomic neuropathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-celiac-disease-in-adults\" class=\"medical medical_review\">Diagnosis of celiac disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fecal-incontinence-in-adults-etiology-and-evaluation\" class=\"medical medical_review\">Fecal incontinence in adults: Etiology and evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fecal-incontinence-in-adults-management\" class=\"medical medical_review\">Fecal incontinence in adults: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastroparesis-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Gastroparesis: Etiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lymphocytic-and-collagenous-colitis-microscopic-colitis-clinical-manifestations-diagnosis-and-management\" class=\"medical medical_review\">Lymphocytic and collagenous colitis (microscopic colitis): Clinical manifestations, diagnosis, and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-celiac-disease-in-adults\" class=\"medical medical_review\">Management of celiac disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=medical-management-of-gastroesophageal-reflux-disease-in-adults\" class=\"medical medical_review\">Medical management of gastroesophageal reflux disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-medical-care-in-adults-with-diabetes-mellitus\" class=\"medical medical_review\">Overview of medical care in adults with diabetes mellitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-delayed-gastric-emptying\" class=\"medical medical_review\">Pathogenesis of delayed gastric emptying</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-of-reflux-esophagitis\" class=\"medical medical_review\">Pathophysiology of reflux esophagitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastroparesis-delayed-gastric-emptying-the-basics\" class=\"medical medical_basics\">Patient education: Gastroparesis (delayed gastric emptying) (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=small-intestinal-bacterial-overgrowth-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=small-intestinal-bacterial-overgrowth-etiology-and-pathogenesis\" class=\"medical medical_review\">Small intestinal bacterial overgrowth: Etiology and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=small-intestinal-bacterial-overgrowth-management\" class=\"medical medical_review\">Small intestinal bacterial overgrowth: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-chronic-pancreatitis\" class=\"medical medical_review\">Treatment of chronic pancreatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-gastroparesis\" class=\"medical medical_review\">Treatment of gastroparesis</a></li></ul></div></div>","javascript":null}